No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological / adverse effects*
-
Antineoplastic Agents, Immunological / immunology
-
Antineoplastic Agents, Immunological / therapeutic use
-
CTLA-4 Antigen / antagonists & inhibitors*
-
CTLA-4 Antigen / immunology
-
Cell Cycle Checkpoints / drug effects
-
Cell Cycle Checkpoints / immunology
-
Humans
-
Immune System Diseases / chemically induced*
-
Immune System Diseases / drug therapy
-
Immune System Diseases / therapy
-
Neoplasms / drug therapy*
-
Neoplasms / immunology
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / immunology
Substances
-
Antineoplastic Agents, Immunological
-
CTLA-4 Antigen
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor